Coronavirus NSP14 drives internal m7G modification to rewire host splicing and promote viral replication.

Coronavirus NSP14 drives internal m7G modification to rewire host splicing and promote viral replication.

Publication date: Aug 10, 2026

SARS-CoV-2 manipulates host gene expression through multiple mechanisms, including disruption of RNA processing. Here, we identify a novel function of the viral non-structural protein 14 (NSP14) in inducing N7-methylguanosine (m7G) modification in the internal sequences of host mRNA. We demonstrate that NSP14 catalyzes the conversion of GTP to m7GTP, which is subsequently incorporated into mRNA by RNA polymerase II, resulting in widespread internal m7G modification. This activity is dependent on NSP14’s N7-methyltransferase (N7-MTase) domain, and the NSP10-NSP14 interaction increases cellular m7G levels primarily by increasing NSP14 protein abundance. NSP14-induced m7G modification is conserved across alpha-, beta-, and gamma-coronaviruses. Mechanistically, we show that this RNA modification is associated with altered splicing, particularly in genes regulating genome stability, RNA metabolism, and nuclear processes. Importantly, using SARS-CoV-2 infection models, we show that viral replication is associated with increased cellular m7G signal, supporting the relevance of this pathway during infection. Inhibition of NSP14 N7-MTase or RNA polymerase II reduces SARS-CoV-2 replication, consistent with a model in which NSP14-induced m7G modification may contribute to viral replication. Our findings reveal a previously unrecognized epitranscriptomic mechanism and suggest that NSP14-induced m7G modification may contribute to the remodeling of host gene expression during coronavirus infection.

Open Access PDF

Concepts Keywords
Coronaviruses 7-methylguanosine
Nsp14 Animals
Nuclear Epitranscriptome
Polymerase Epitranscriptomics
Remodeling Exoribonucleases
Exoribonucleases
Guanosine
Guanosine
HEK293 Cells
Host-Pathogen Interactions
Humans
Methyltransferases
Methyltransferases
NSP14 protein, SARS-CoV-2
RNA Methylation
RNA Splicing
RNA, Messenger
RNA, Messenger
SARS-CoV-2
Viral Nonstructural Proteins
Viral Nonstructural Proteins
Virus Replication

Semantics

Type Source Name
pathway KEGG Viral replication
pathway KEGG RNA polymerase
disease MESH genome stability
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH infection
disease MESH coronavirus infection
drug DRUGBANK Methionine
pathway REACTOME Reproduction
disease MESH cap
pathway REACTOME Metabolism
drug DRUGBANK Guanine
pathway REACTOME Translation
drug DRUGBANK Guanosine
pathway REACTOME Methylation
pathway REACTOME mRNA Splicing
disease MESH hepatitis
disease MESH virus infection
disease MESH FBS
drug DRUGBANK Methylcellulose
drug DRUGBANK Phosphate ion
disease MESH PBS
drug DRUGBANK Human Serum Albumin
disease MESH Image
disease MESH Rad
drug DRUGBANK Tromethamine
drug DRUGBANK Zoledronic acid
drug DRUGBANK Cysteamine
drug DRUGBANK Gelatin
disease MESH glass
drug DRUGBANK Ethanol
drug DRUGBANK Gold
disease MESH Mas
drug DRUGBANK Myricetin
disease MESH Fac
drug DRUGBANK Ademetionine
drug DRUGBANK ATP
disease MESH HSS
drug DRUGBANK Flunarizine
drug DRUGBANK Adenosine
drug DRUGBANK Cytidine
disease MESH STAR
drug DRUGBANK Coenzyme M
disease MESH Hs2
disease MESH included
pathway REACTOME mRNA Capping
drug DRUGBANK Methylenedioxyethamphetamine
drug DRUGBANK Methylene blue
drug DRUGBANK Dimethyl sulfoxide
disease MESH ARS
disease MESH common cold
disease MESH respiratory diseases
disease MESH bronchitis
drug DRUGBANK Amino acids
drug DRUGBANK Tretamine
drug DRUGBANK Dactinomycin
pathway REACTOME Chromatin modifying enzymes
drug DRUGBANK Fenamole
pathway REACTOME Nucleotide biosynthesis
disease MESH mul
drug DRUGBANK Naproxen
disease MESH tumorigenesis
disease MESH Flavivirus infection
drug DRUGBANK Fluorouracil
drug DRUGBANK Favipiravir
drug DRUGBANK Ribavirin
disease MESH dis
drug DRUGBANK Esomeprazole
disease MESH pneumonia
disease MESH cancer
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH Park
pathway KEGG Ribosome
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Formaldehyde
disease MESH severe acute respiratory syndrome
disease MESH Kaposi’s sarcoma
disease MESH Flaviviridae infection
drug DRUGBANK Deoxythymidine
drug DRUGBANK 7-Methylguanosine

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *